An open comparison of clozapine and risperidone in treatment-resistant schizophrenia

Pharmacopsychiatry

Volumn 31, Issue 1, 1998, Pages 25-29

  Flynn, S W ^a,b   MacEwan, G W ^c   Altman, S ^a,b   Kopala, Lili C ^d   Fredrikson, Diane H ^a   Smith, G N ^b   Honer, W G ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b RIVERVIEW HOSPITAL   (Canada)

^c St Vincent's Hospital   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; PSYCHOSOCIAL WITHDRAWAL; SCHIZOPHRENIA; SCORING SYSTEM;

EID: 0031891624     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979291     Document Type: Article

References (31)

1. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, fourth edition. Washington, D. C. (1994)
2. Baldessarini, R., F. Frankenburg: Clozapine: a novel antipsychotic agent. N. Engl. J. Med. 324 (1991) 746-754
3. th Annual Meeting of the American Psychiatric Association (1995) NR485: 185
4. Breier, A., R. W. Buchanan, D. Irish: Clozapine treatment of outpatients with schizophrenia 2: outcomes and long-term response patterns. Hospital and Community Psychiatry 44 (1993) 1145-1149
5. Buchanan, R. W.: Clozapine: efficacy and safety. Schizophrenia Bull. 21 (1995) 580-591
6. Cavallaro, R., C. Colombo, E. Smeraldi: A pilot, open study on the treatment of refractory schizophrenia with risperidone and clozapine. Human Psychopharmacol. 10 (1995) 231-234
7. Ceskova, E., J. Svestka: Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses. Pharmacopsychiat. 26 (1993) 121-124
8. Chouinard, G., B. Jones, G. Remington, D. Bloom, D. Addington, G. MacEwan, A. Labelle, L. Beauclair, W. Arnott: A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J. Clin. Psychopharmacol. 13 (1993) 25-40
9. Frances, A., J. P. Docherty, D. A. Kahn (ed.): The Expert Consensus Guideline Series: Treatment of Schizophrenia. J. Clin. Psychiatry 57 (1996) suppl 12 B.
10. Fredrikson, D. H., J. M. Steiger, G. W. MacEwan, S. Altman, L. C. Kopala, S. W. Flynn, P. F. Liddle, W. G. Honer: PANSS symptom factors in schizophrenia. Schizophrenia Res. 24 (1997) 15
11. Guy, W. (ed.): ECDEU assessment manual for psychopharmacology, revised. Rockville Pike, MD (1976)
12. Heinrich, K., E. Klieser, E. Lehmenn: Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double blind, randomized trial. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 18 (1994) 129-137
13. Honer, W. G., G. N. Smith, G. W. MacEwan, L. C. Kopala, S. Altman: Diagnostic reassessment and treatment response in schizophrenia. J. Clin. Psychiatry 55 (1994) 528-532
14. Honer, W. G., G. W. MacEwan, L. C. Kopala, S. Altman: A clinical study of clozapine treatment and predictors of response in a Canadian sample. Can. J. Psychiatry 40 (1995) 208-211
15. Kane, J., G. Honigfeld, J. Singer, H. Meltzer, Clozaril Collaborative Study Group: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine/benztropine. Arch. Gen. Psychiatry 45 (1988) 789-796
16. Kay, S., A. Fiszbein, L. A. Opler: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull. 13 (1987) 261-276
17. Lacey, R. L., S. H. Preskorn, G. S. Jerkovich: Is risperidone a substitute for clozapine for patients who do not respond to neuroleptics? Am. J. Psychiatry 152 (1995) 1401
18. Lieberman, J. A., A. Z. Safferman, S. Pollack: Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am. J. Psychiatry 151 (1994) 1744-1752
19. th Annual Meeting of the American Psychiatric Association (1995) NR228:117
20. Lindenmayer, J. P., A. Iskander, M. Park, R. Smith, F.-S. Apergi, P. Czobor: Psychopathological and neuropsychological profile of clozapine vs. risperidone in refractory schizophrenics. Schizophrenia Res. 24 (1997) 195
21. MacEwan, G. W: New antipsychotic medications: do research results relate to clinical practice? Can. J. Psychiatry 38 (1993) S75-S79
22. Marder, S. R., R. C. Meibach: Risperidone in the treatment of schizophrenia. Am. J. Psychiatry 151 (1994) 825-835
23. May, P., S. Dencker, J. Hubbard, K. Midha, R. Liberman: A systematic approach to treatment resistance in schizophrenic disorders. In: Dencker, S. J., Kulhanek, F. (ed.): Treatment Resistance in Schizophrenia. Vieweg, Braunschweig/Wiesbaden (1988) 22-33
24. Meltzer, H. Y., B. Bastani, K. Y. Kwon, L. F. Ramirez, S. Burnett, J. Sharpe: A prospective study of clozapine in treatment-resistant schizophrenic patients. Psychopharmacol. 99 (1989) S68-S72
25. Naber D., R. Holzbach, C. Perro, H. Hippius: Clinical management of clozapine patients in relation to efficacy and side-effects. Br. J. Psychiatry 160 suppl. 17 (1992) 54-59
26. Peuskens, J., the Risperidone Study Croup: Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multi-centre, double-blind, parallel-group study versus haloperidol. Br. J. Psychiatry 166 (1995) 712-726
27. Picka, D., R. R. Owen, R. E. Litman, P. E. Konicki, R. Gutierrez, M. H. Rapoport: Clinical and biologic response to clozapine in patients with schizophrenia. Arch. Gen. Psychiatry 49 (1992) 345-353
28. Schooler, N. R.: Translating treatment research findings into clinical action. Am. J. Psychiatry 151 (1994) 1719-1721
29. Smith, G. N., G. W. MacEwan, R. J. Ancill, W. G. Honer, T. S. Ehmann: Diagnostic confusion in treatment-refractory psychotic patients. J. Clin. Psychiatry 53 (1992) 197-200
30. Tanner, T. B., R. Ganguli, R. Ready, M. Allen, K. Field: Risperidone for treatment-refractory schizophrenia. Am. J. Psychiatry 152 (1995) 1233
31. Umbricht, D., J. M. Kane: Risperidone: Efficacy and safety. Schizophrenia Bull. 21 (1995) 593-606